Response of thymoma to cetuximab

Lancet Oncology

Volumn 8, Issue 5, 2007, Pages 449-450

  Farina, Gabriella ^a   Garassino, Marina C ^a   Gambacorta, Marcello ^b   La Verde, Nicla ^a   Gherardi, Giorgio ^a   Scanni, Alberto ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; OCTREOTIDE; PREDNISONE;

ACNE; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DISEASE COURSE; DRUG ERUPTION; DRUG RECEPTOR BINDING; DRUG RESPONSE; FEMALE; GENE OVEREXPRESSION; HEART METASTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MEDIASTINUM MASS; MULTIPLE CYCLE TREATMENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH; THYMOMA; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMOMA; THYMUS NEOPLASMS;

EID: 34247186500     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70141-9     Document Type: Article

References (8)

1. Loehrer P., Chen M., Kim K., et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15 (1997) 3093-3099
2. Loehrer Sr. P., Wang W., Johnson D., et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol 22 (2004) 293-299
3. Palmieri G., Montella L., and Martignetti A. Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 94 (2002) 1414-1420
4. Ionescu D., Sasatomi E., Cieply K., et al. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer 103 (2005) 630-636
5. Moroni M., Veronese S., Benvenuti S., et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6 (2005) 279-286
6. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
7. Henley J., Cummings O., and Loeherer Sr. P. Tyrosine kinase receptor expression in thymomas. J Cancer Res Clin Oncol 130 (2004) 222-224
8. Kurup A., Burns M., Dropcho S., Pao W., and Loeherer Sr. P. Phase II study of gefitinib treatment in advanced thymic malignancies. J Clin Oncol 23 part 1 (2005) 7068 (abstr).